Journal Article Summary
The article investigates the human vitamin D receptor (hVDR) and its interactions with various ligands, particularly focusing on how specific mutations can alter its function. Understanding the hVDR is crucial because it plays a significant role in regulating calcium and phosphate levels in the body, which are vital for bone health. Mutations in this receptor can lead to diseases such as Rickets and Osteoporosis, making it important to explore how these mutations affect receptor activity and ligand binding.
Researchers used a combination of rational design and random mutagenesis to create variants of the hVDR and tested their ability to bind and activate in response to different ligands, including cholecalciferol, a precursor to the active form of vitamin D. They engineered a specific mutant, H305F/H397Y, which demonstrated the ability to bind cholecalciferol at low concentrations, unlike the wild-type receptor. The study found that this mutant had a significantly increased sensitivity to both lithocholic acid and cholecalciferol, indicating that the mutations altered the receptor's binding pocket to accommodate these ligands more effectively.
However, the study has limitations, including the reliance on in vitro models, which may not fully replicate the complexities of human physiology. Patients and caregivers should be aware that while these findings provide insights into receptor function, they do not directly translate into clinical recommendations. It is essential for individuals to discuss any concerns about vitamin D metabolism or related health issues with a healthcare professional, who can provide personalized advice based on the latest research and individual health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ousley Amanda M., Castillo Hilda S., Duraj-Thatte Anna, Doyle Donald F., Azizi Bahareh. A Human Vitamin D Receptor Mutant Activated by Cholecalciferol. The Journal of steroid biochemistry and molecular biology 2011. DOI: 10.1016/j.jsbmb.2011.03.001. PMID: 21397016. PMCID: PMC3105188.
Featured Pill Pals Product
Ergocalciferol 1,250 mcg Capsules --- 4 Count / Taken Once A Week --- Generic for Drisdol --- Bion Pharma
Ergocalciferol 1,250 mcg Capsules --- 4 Count / Taken Once A Week --- Generic for Drisdol --- Bion Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
